Variablea | Rate of pregnancy n (%) | Odds ratio (95% CI) | P value |
---|---|---|---|
Embryo vitrification stage | |||
 CSE | 198/502 (39.44%) | 2.1 (1.6–2.8) | 0.001$ |
 BSE | 100/536 (18.66%) | ||
Embryo quality | |||
 Top Q ET | 216/684 (31.5%) | 63.31 (3.899–1028) | 0.0001$ |
 Non-top Q ET | 0/68 (0%) | ||
Endometrial preparation | |||
 Natural | 70/240 (29.1%) |  | 0.09$$ |
 Stimulated | 204/680 (30.0%) | ||
 Replacement | 17/90 (18.8%) | ||
Culture use | |||
 CSE to BSE | a: a = 5.44 (3.89–7.60) b: b = 5.8 (4.1–8.1) c: c = 4.7 (3.1–7.0) | 0.0001$ | |
  a- Clinical PR | 116/194 (59.7%) | ||
  b- Chemical PR | 125/194 (64.1%) | ||
  c- Ongoing PR | (87/165) (52.7%) | ||
 Non-Culture | |||
  a- Clinical PR | 182/848 (21.4%) | ||
  b- Chemical PR | 201/848 (23.7%) | ||
  c- Ongoing PR | 80/450 (17.7%) | ||
Ovulation Triggering by HCG | |||
 Yes | 212/610 (34.7%) | 2.45 (1.78–3.34) | 0.0001$ |
 No | 66/370 (17.8%) |